Ascendis Pharma (spons. ADRs) Aktie
197,00
EUR
+2,00
EUR
+1,03
%
229,35
USD
+1,13
USD
+0,50
%
Werbung
Ascendis Pharma (spons. ADRs) Aktie Analyse
| 24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
| 26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
| 26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung